DNMT3A and atherosclerosis: In summary, atherosclerosis and CHIP form a self-perpetuating cycle in which inflammation drives HSC proliferation and mutation accumulation, while mutant clones, particularly those with TET2 and DNMT3A alterations, boost pro-inflammatory signaling and accelerate vascular dysregulation.